The dynamics of hippocampal sensory gating during the development of morphine dependence and withdrawal in rats

Neuroscience Letters

Volumn 382, Issue 1-2, 2005, Pages 164-168

  Zheng, Jiawei ^a,b   Yang, Yan ^a   Tian, Shaohua ^a,b   Chen, Jin ^a   Wilson, Fraser A W ^a   Ma, Yuanye ^a,b  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Dependence development; Dopamine; Hippocampal; Morphine; Sensory gating; Withdrawal

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; MORPHINE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHANNEL GATING; CLICK; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; EVOKED AUDITORY RESPONSE; EXAMINATION; HIPPOCAMPUS; INJECTION; MALE; MOLECULAR DYNAMICS; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ACOUSTIC STIMULATION; ANALGESICS, OPIOID; ANIMALS; AUDITORY PERCEPTION; DOPAMINE; DOPAMINE ANTAGONISTS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; HALOPERIDOL; HIPPOCAMPUS; MORPHINE; MORPHINE DEPENDENCE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 19444375970     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.03.010     Document Type: Article

References (37)

1. L.E. Adler, L. Hoffer, H.T. Nagamoto, M.C. Waldo, M.A. Kisley, and J.M. Giffith Yohimbine impairs P50 auditory sensory gating in normal subjects Neuropsychopharmacology 10 1994 249 257
2. L.E. Adler, C. Hope, L.D. Hoffner, C. Stephen, D. Young, and G. Gerhardt Bromocriptine impairs P50 auditory sensory gating in normal control subjects Biol. Psychiatry 35 1994 630
3. L.E. Adler, A. Olincy, E. Cawthra, M. Hoffer, H.T. Nagamoto, L. Amass, and R. Freedman Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism Neuropsychopharmacology 24 2001 671 679
4. L.E. Adler, A. Olincy, M. Waldo, J.G. Harris, J. Griffith, K. Stevens, K. Flach, H. Nagomoto, P. Bickford, S. Leonard, and R. Freedman Schizophrenia, sensory gating, and nicotinic receptors Schizophr. Bull. 24 1998 189 202
5. L.E. Adler, G. Rose, and R. Freedman Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol Biol. Psychiatry 21 1986 787 798
6. A. Ambrosini, V. de Pasqua, J. Afra, P.S. Sandor, and J. Schoenen Reduced gating of middle-latency auditory evoked potentials (P50) in migranine patients: another indication of abnormal sensory processing? Neurosci. Lett. 306 2001 132 134
7. P.C. Bickford-Wimer, H. Nagamoto, R. Johnson, L.E. Adler, M. Egan, G.M. Rose, and R. Freedman Auditory sensory gating in hippocampal neurons: a model system in the rat Biol. Psychiatry 27 1990 183 192
8. D.L. Braff Information processing and attention dysfunctions in schizophrenia Schizophr. Bull. 19 1993 233 259
9. H.J. Crawford, D. McClain-Furmanski, N. Castognoli Jr., and K. Castagnoli Enhancement of auditory sensory gating and stimulus-bound gamma band (40 Hz) oscillations in heavy tobacco smokers Neurosci. Lett. 317 2002 151 155
10. D. Crippens, and T.E. Robinson Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial striatum studied with microdialysis Brain Res. 650 1994 56 62
11. C.M. Cullum, J.G. Harris, M.C. Waldo, E. Smernoff, A. Madison, H.T. Nagamoto, J. Griffith, L.E. Adler, and R. Freedman Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia Schizophr. Res. 10 1993 131 141
12. N.M.W.J. De Bruin, B.A. Ellenbroek, E.L.J.M. Van Luijtelaar, A.R. Cools, and K.E. Stevens Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell Neuroscience 105 2001 169 180
13. N.M.W.J. De Bruin, E.L.J.M. Van Luijtelaar, A.R. Cools, and B.A. Ellenbroek Filtering disturbances in schizophrenic patients. Gating of auditory evoked potentials and prepulse inhibition of the acoustic startle response compared. Emphasis on the role of dopamine Curr. Neuropharmacol. 1 2003 109 121
14. M. Diana, M. Melis, A.L. Muntoni, and G.L. Gessa Mesolimbic dopaminergic decline after cannabinoid withdrawal Proc. Natl. Acad. Sci. USA 95 1998 10269 10273
15. M. Diana, A.L. Muntoni, M. Pistis, M. Melis, and G.L. Gessa Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal Eur. J. Neurosci. 11 1999 1037 1041
16. A.J. Eisch, M. Barrot, C.A. Schad, D.W. Self, and E.J. Nestler Opiates inhibit neurogenesis in the adult rat hippocampus Proc. Natl. Acad. Sci. USA 97 2000 7579 7584
17. S.B. Floresco, C.D. Blaha, C.R. Yong, and A.G. Phillips Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection J. Neurosci. 21 8 2001 2851 2860
18. F. Jessen, C. Kucharski, T. Fries, A. Papassotiropoulos, K. Hoenig, W. Maier, and R. Heun Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease Am. J. Psychiatry 158 2001 1319 1321
19. R.G. Johnson, K.E. Stevens, and G.M. Rose 5-Hydroxytryptamine-2 receptors modulate auditory filtering in the rat J. Pharmacol. Exp. Ther. 285 1998 643 650
20. V.A. Keith, R.S. Mansbach, and M.A. Geyer Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle Biol. Psychiatry 30 1991 557 566
21. G.F. Koob, and F.E. Bloom Cellular and molecular mechanisms drug dependence Science 242 1988 715 723
22. G.F. Koob, P.P. Sanna, and F.E. Bloom Neuroscience of addiction Neuron 21 1998 467 476
23. M. Krause, W.E. Hoffmann, and M. Hajos Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats Biol. Psychiatry 53 2003 244 253
24. G.A. Light, D. Malaspina, M.A. Geyer, B.M. Luber, E.A. Coleman, H.A. Sackeim, and D.L. Braff Amphetamine disrupts P50 suppression in normal subjects Biol. Psychiatry 46 1999 990 996
25. A.L. Muntoni, M. Diana, and G.L. Gessa Repeated naltrexone administration accelerates resolution of morphine somatic withdrawal signs in morphine-dependent rats Eur. J. Pharmacol. 301 1996 R9 R10
26. J.V. Patterson, Y. Jin, M. Gierczak, W.P. Hetrick, S. Potkin, W.E. Bunney, and C.A. Sandman Effects of temporal variability on P50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trail analysis Arch. Gen. Psychiatry 57 2000 57 64
27. L. Pu, G.B. Bao, N.J. Xu, L. Ma, and G. Pei Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates J. Neurosci. 22 5 2002 1914 1921
28. A. Salamy, M. Salfi, and G. Fein Sensory gating deficit following cocaine exposure in the rat Neuropsychobiology 36 2 1997 83 86
29. U. Schridde, and G. Van Luijtelaar The role of hippocampal theta activity in sensory gating in the rat Physiol. Behav. 74 2001 257 266
30. R. Spanagel, and F. Weiss The dopamine hypothesis of reward: past and current status Trends Neurosci. 22 1999 521 527
31. K.E. Stevens, L.L. Fuller, and G.M. Rose Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating Brain Res. 555 1991 91 98
32. K.E. Stevens, and K.D. Wear Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models Pharmacol. Biochem. Behav. 57 1997 869 874
33. R. Stoop, and E. Pralong Functional connections and epileptic spread between hippocampus, entorhinal cortex and amygdala in a modified horizontal slice preparation of the rat brain Eur. J. Neurosci. 12 10 2000 3651 3663
34. L.W. Swanson The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat Brain Res. Bull. 9 1982 321 353
35. E.Y. Uc, R.D. Skinner, R.L. Rodnitzky, and E. Garcia-Rill The midlatency auditory evoked potential P50 is abnormal in Huntington's disease J. Neurol. Sci. 212 2003 1 5
36. S.R. Vorel, X. Liu, R.J. Hayes, J.A. Spector, and E.L. Gardner Relapse to cocaine-seeking after hippocampal theta burst stimulation Science 292 2001 1175 1178
37. R.A. Wise Drug-activation of brain reward pathways Drug Alcohol Depend. 51 1998 13 22